Cancer and Nanotechnology

Nanotechnology treat the cancer cell by abrogating tumors making less harm to healthy tissue and organs, just as the discovery and end of disease cells before they structure tumors. More efforts are made to improve cancer treatment through nanotechnology are at the development stage. The use of nanotechnology in development treatment offers some invigorating expected results, including the probability of destroying danger tumors with unimportant mischief to healthy tissue and organs, and furthermore the disclosure and end of infection cells before they frame tumors.

 

  • Chemotherapy
  • Nano-enabled immunotherapy
  • Augmenting radiotherapy
  • Gene therapy

Related Conference of Cancer and Nanotechnology

March 21-22, 2022

39th Global Summit on Nanoscience and Technology

Tokyo, Japan
March 25-26, 2022

18th Nanotechnology and Nanomedicine Congress

Berlin, Germany
April 04-05, 2022

2nd International Conferences on Nanotechnology & Chemistry

Geneva, Switzerland
April 27-28, 2022

34th Nano Congress for Future Advancements

Barcelona, Spain
May 20-21, 2022

39th Global Nanotechnology Congress

London, UK
July 11-12, 2022

25th World Nanotechnology Congress

Singapore City, Singapore
July 11-12, 2022

30th International Conference on Nanomedicine and Nanomaterials

Singapore City, Singapore
July 18-19, 2022

36th International Conference on Neonatology and Perinatology

Amsterdam, Netherlands
September 27-28, 2022

2nd International Conference on Nanomedicine and Drug Delivery

Bangkok, Thailand
October 13-14, 2022

24th Materials Science and Nano Tech Expo

Osaka, Japan
October 24-25, 2022

33rd World Nano Conference

Dublin, Ireland
November 08-09, 2022

3rd World Congress on Nanotechnology and Advanced Materials

Budapest, Hungary
November 16-17, 2022

36th International Conference on Nanotechnology & Expo

Barcelona, Spain
December 05-06, 2022

Applied Nanotechnology Summit

Paris, France

Cancer and Nanotechnology Conference Speakers

Recommended Sessions

Related Journals

Are you interested in